Mayo Clin Proc, June 2002, Vol 77 Treatment of Medication-Refractory Mental Illness 553 Figure 1. Bitemporal electrode placement (left), unilateral el
|
|
- Mariah Kennedy
- 5 years ago
- Views:
Transcription
1 552 Concise Review for Clinicians Electroconvulsive Therapy and Newer Modalities for the Treatment of Medication-Refractory Mental Illness KEITH G. RASMUSSEN, MD; SHIRLENE M. SAMPSON, MD; AND TERESA A. RUMMANS, MD Severe mental illnesses often remain chronic and refractory to medication, leading to substantial morbidity and mortality. For more than 60 years, electroconvulsive therapy has been the only nonpharmacological psychiatric procedure available to treat severe or medication-refractory major depressive disorder and other psychiatric conditions. Memory dysfunction remains the most serious adverse effect, and current research focuses on attempts to ameliorate this complication. Transcranial magnetic stimulation and vagus nerve stimulation, 2 new neuropsy- chiatric technologies, are emerging as possible additions to our therapeutic armamentarium. Besides providing therapeutic benefits, these 3 methods may help elucidate the pathophysiology of psychiatric illness. Mayo Clin Proc. 2002;77: ECT = electroconvulsive therapy; EEG = electroencephalogram; TMS = transcranial magnetic stimulation; VNS = vagus nerve stimulation The use of chemically induced seizures for treatment of mental disorders is documented in various reports dating back centuries. 1 The first systematic descriptions of convulsive therapy were provided in 1934 by Ladislaus von Meduna, who used injections of camphor liniment to induce seizures in patients with schizophrenia, many of whom responded dramatically. 1 His technique was quickly recognized for its value in psychiatric therapeutics and was adopted worldwide within a few years of its introduction. Other chemicals, such as pentylenetetrazol, were also used to induce seizures. This pharmacoconvulsive therapy, although beneficial, was fraught with problems, such as unreliable induction of seizures, and was frightening to patients. Thus, when Cerletti and Bini introduced the technique of electrically induced seizures in 1938, it was welcomed and quickly became the preferred method. 1 ELECTROCONVULSIVE THERAPY Methods The fundamental principle of electroconvulsive therapy (ECT) is the application of an electrical current through electrodes applied to the patient s head to induce a seizure. The patient is first anesthetized with a short-acting intravenous agent, usually methohexital or another barbiturate. From the Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. A question-and-answer section appears at the end of this article. Individual reprints of this article are not available. Address correspondence to Keith G. Rasmussen, MD, Department of Psychiatry and Psychology, Mayo Clinic, 200 First St SW, Rochester, MN ( rasmussen.keith@mayo.edu). Next, muscular paralysis is achieved with use of succinylcholine to block the strong muscular contractions that ordinarily would occur in a generalized tonic-clonic seizure. Oxygen is administered via positive pressure ventilation; intubation is not routinely used in ECT. The electrocardiogram, pulse oximetry, and vital signs are monitored continuously throughout the procedure. After anesthesia and muscular paralysis are achieved, the 2 treatment (or stimulus) electrodes, which are about the size of a silver dollar, are applied to the patient s head. They are connected to the ECT machine via cables. When the treatment button on the machine is pressed, a series of brief pulses of electrical current is passed through the stimulus electrodes into the brain, causing a generalized seizure. The amount of electricity needed to induce a seizure varies considerably from patient to patient. Modern ECT machines are equipped so that the electrical stimulus is quantified precisely. At the first treatment session, a small amount, or dose, of electricity is applied. If no seizure ensues within 20 seconds or so, a larger dose is applied. This stepwise progression of successively increasing doses of electricity is continued until a seizure occurs. This method of titrating the electrical dose ensures that each patient receives the appropriate amount of electrical charge. After the electrical stimulus is passed, the resultant seizure is detectable by inspection of the continuously displayed electroencephalogram (EEG), equipped on all modern ECT machines. A second method for confirming the presence of the seizure is to observe the convulsive movements in a limb with a blood pressure cuff (either on the forearm or the calf) inflated well above systolic pressure Mayo Clin Proc. 2002;77: Mayo Foundation for Medical Education and Research
2 Mayo Clin Proc, June 2002, Vol 77 Treatment of Medication-Refractory Mental Illness 553 Figure 1. Bitemporal electrode placement (left), unilateral electrode placement (middle), and bifrontal electrode placement (right). before succinylcholine is injected, thus isolating the muscles distal to the cuff from the paralyzing effects of the succinylcholine. The seizure usually lasts 30 to 60 seconds. Seizure termination is confirmed by cessation of the spikeand-wave activity on the EEG and of convulsive movements in the cuffed limb. Within a few minutes thereafter, the patient breathes independently and is ready to be taken to the recovery room. Usually within half an hour, the patient is sufficiently awake and alert to go back to the hospital room or to go home if on outpatient status and accompanied by a responsible adult. The treatments are repeated 2 or 3 times per week until there is maximal clinical improvement. Typical courses of ECT are 8 to 10 treatments. After this series of treatments is completed, the patient is then treated with medication therapy or continued weekly to monthly ECT treatments for up to 6 months, a technique known as continuation ECT, to prevent relapse of the psychiatric condition. If the intermittent schedule of treatments extends beyond 6 months, it is referred to as maintenance ECT. Several aspects of the ECT technique affect efficacy and adverse effects. The most prominently studied is the site of stimulus electrode placement on the head (Figure 1). The original placement was bilateral, in which each electrode is placed on the temporal fossa on each side of the head (the so-called bitemporal position). One alternative placement currently in use is the unilateral position, in which 1 electrode is placed on the temporal fossa on the right side as in the bitemporal position, but the other electrode is placed just to the right of the vertex of the head. In this placement, the electrical current is concentrated away from the language areas on the left side of the brain, thus lessening the memory impairment that is common with ECT (see subsequent discussion). Another electrode placement, also designed to lessen ECT-induced memory impairment, is bifrontal, in which the electrodes are placed on either side of the forehead. In this placement, electrical current is concentrated away from mesial temporal lobe structures involved with memory formation. Whether the well-known therapeutic efficacy of traditional bitemporal ECT is preserved with unilateral or bifrontal ECT is unclear. A second technical factor is the dose of electrical charge used during ECT. Typical electrical doses used in ECT range from 25 to 504 mc, most of which is shunted across the scalp and does not reach the brain. The electrical dose may affect both therapeutic efficacy and cognitive adverse effects. For example, in unilateral ECT, giving a dose of electricity barely enough to induce a seizure (the seizure threshold) is associated with low therapeutic efficacy, whereas giving too much electrical charge results in excessive cognitive dysfunction. 2 Precise quantification of the electrical dose ensures that the correct amount is administered. A third technical issue in ECT concerns treatment frequency. Usually in the United States, treatment frequency is thrice weekly, but several studies have shown that twice weekly may yield equivalent therapeutic benefit (albeit more slowly) with much less cognitive impairment. 1 The choice of electrode placement, stimulus dose, and treatment frequency is individualized and depends on such factors as patient age and severity of illness. Indications Electroconvulsive therapy is the most effective treatment for major depression, with average response rates of 70% to 90% compared with about 60% to 70% for antidepressant medications. 1 It is given to patients whose condition is refractory to or who are intolerant of antidepressant medications, who are so ill (eg, suicidal, catatonically stuporous, refusing food and fluids) that the most rapid treatment is
3 554 needed, or who express preference for it based on past experience. 3 Additionally, ECT is highly effective for mania and certain cases of schizophrenia. 3 An intriguing series of reports suggests that ECT can help ameliorate the motor symptoms of Parkinson disease and various other movement disorders, such as tardive dystonia, tardive dyskinesia, and neuroleptic-induced malignant catatonia (also termed neuroleptic malignant syndrome). 1 Risks and Adverse Effects Electroconvulsive therapy is actually a safe procedure. In fact, the death rate due to treatment is approximately 1 per 10,000 patients. 1 Although ECT has no absolute contraindications, relative contraindications include presence of brain tumor with increased intracranial pressure, unstable myocardial function, and American Society of Anesthesiology risk level 4 or 5. 3 During the seizure, heart rate and blood pressure increase sharply. Thus, patients with cardiac disease, such as coronary atherosclerosis, congestive heart failure, or cardiac dysrhythmias, have a higher risk of cardiovascular complications. Therefore, any patient with suspected unstable or untreated cardiac illness should undergo evaluation before ECT. Additionally, any unstable vascular malformation, such as an arteriovenous fistula or a leaky aneurysm, would be at risk of rupture during ECT. Thorough evaluation and stabilization of any existing cardiovascular condition before treatment make ECT safe even for many patients with advanced disease. For patients with a known increase in intracranial pressure, such as those with brain tumors, ECT is relatively contraindicated. 3 However, ECT has been used safely in patients with various neurologic conditions, such as dementia and epilepsy. In contrast to the rarity of medical complications associated with ECT, memory disturbance of varying severity is common and is by far the most bothersome adverse effect. Electroconvulsive therapy induced memory impairment takes 3 forms. The first is posttreatment confusion. Typically, it takes a few minutes to half an hour for a patient to become fully alert and oriented after treatment. Occasionally, especially in elderly patients receiving thrice-weekly treatment with bitemporal electrode placement, the period of posttreatment confusion persists for several hours or even days. This interictal delirium is reversible with cessation of treatment. The second type of memory impairment with ECT is anterograde amnesia. This refers to the inability to recall information learned after the treatments have begun. An example is when a patient has a conversation with somebody early in the day and then forgets it later on that day. Extensive research has documented that ECT-induced anterograde amnesia is temporary. 2 The third and most bothersome type of ECT-induced memory impairment is retrograde amnesia, forgetting things that happened before the course of treatments. An example is forgetting a movie that was seen a week before the first treatment. Events of several months before treatment are most likely forgotten. Usually, only a few events, such as conversations, are forgotten, but patients occasionally forget most of the events of this period. Additionally, patients sometimes have sporadic episodes of forgetting personal life events that happened several years before treatment. Some of the forgotten events may never be remembered. Thus, during the informed consent process, it is important to discuss this issue with patients and to monitor their memory function during the course of treatments. Mechanism of Action The precise mechanism of action of ECT is unknown. Traditional theories have been based on neurotransmitter and neuroreceptor studies in animals and probably have limited utility in extrapolation to humans. However, some of the consistent findings in the animal literature include down-regulation of postsynaptic β-receptors and up-regulation of postsynaptic serotonin type 2 receptors. 1 An intriguing finding in humans is that potent reduction of cerebral blood flow in the frontal lobes along with induced slowing of EEG frequencies in the same region correlates strongly with therapeutic outcome in ECT. 4,5 Thus, the effects of treatments on frontal lobe function, an area implicated in the pathophysiology of depressive illness, may be relevant in the mechanism of action of ECT. Current Research A particularly common problem in ECT practice is the high relapse rates of depressive illness after a successful course of treatments. 6 Standard practice is to give patients antidepressant medications after ECT. Another strategy is continuation and maintenance ECT, in which treatments are continued at spaced intervals (eg, weekly, biweekly, or monthly) for a few months or even years after the successful treatment sessions. Current research is elucidating treatment strategies to prevent relapse of depression after ECT. Another common problem is memory impairment. Current ECT research is evaluating alternative electrode placements to lessen ECT-induced cognitive adverse effects. For example, the bifrontal placement allows the electrical current to be concentrated in the frontal lobes, where clinical efficacy may be most important, but bypasses the mesial temporal lobes, areas thought to be most critical for memory impairment. An exciting area of ECT research involves the use of sophisticated brain imaging (eg, positron emission tomog-
4 Mayo Clin Proc, June 2002, Vol 77 Treatment of Medication-Refractory Mental Illness 555 raphy and single-photon emission computed tomography) and computerized EEG technology to elucidate the mechanism of action of ECT and even the neurobiological basis of depressive illness. As mentioned previously, successful courses of ECT produce sharp (although reversible) reductions of cerebral blood flow in the frontal lobes as well as induction of delta and theta EEG activity in the same region. 4,5 Additionally, computer analysis of the EEG during ECT seizures is helping to distinguish therapeutic from nontherapeutic treatments. 7 This line of inquiry should help us understand brain mechanisms in the action of ECT and may help lead to other treatment technologies. FUTURE DIRECTIONS Because ECT involves repeated administrations of general anesthesia, some risk of medical complications, and memory impairment, less invasive neuropsychiatric treatments are needed. The 2 emerging technologies that appear promising are transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS). A novel and safe method of brain stimulation first used in 1985, TMS consists of applying magnetic fields to the brain through a metal coil placed over the cranium. 8 During a typical TMS session, the patient sits comfortably awake throughout the whole procedure. It was first used clinically to stimulate the motor cortex to record electromyographic activity in certain muscle groups to test the integrity of the motor pathways, analogous to the use of evoked potentials to test the integrity of sensory pathways. Transcranial magnetic stimulation can be used to study cortical neurophysiology or as a possible therapeutic intervention for psychiatric disorders. In recent years, much excitement has developed regarding the possibility that TMS can treat depression. 8 In contrast to ECT, TMS requires no anesthesia, does not induce seizures, and does not appear to cause cognitive deficits. Studies directly comparing ECT to TMS are limited thus far but suggest comparable antidepressant efficacy. 9 At publication of this article, TMS has not been approved for the treatment of depression. Based on early work in animals showing that electrical stimulation of the vagus nerve stopped seizures in dogs, an implantable device capable of stimulating the vagus nerve in humans was developed and studied. Vagus nerve stimulation involves implantation of an electrical generator (about the size and shape of a cardiac pacemaker) into the left chest wall. This is connected to a wire, which in turn is connected to the vagus nerve in the neck. An implantable vagus nerve stimulator (NeuroCybernetic prosthesis [Cyberonics, Inc, Houston, Tex]) is now commercially available, has been approved by the Food and Drug Administration for medication-refractory partial-onset epilepsy, and has been implanted in thousands of humans. The function of the electrical generator, including modification of the intensity of electrical stimulation to the vagus, is monitored and modified by a portable wand connected to a computer and held over the generator site above the skin noninvasively. Long-term safety has been established. This stimulator has been successful in patients with refractory epilepsy and has been found to be safe and effective by the American Academy of Neurology. 10 Based on apparent antidepressant activity in epileptic patients and effects of VNS on cortical blood flow and neurochemistry that are similar to the effects of antidepressant treatments, a preliminary open trial of VNS in patients with medicationrefractory depression was undertaken, and it was found to be successful in a substantial proportion. 11 At publication of this article, the NeuroCybernetic prosthesis has not been approved by the Food and Drug Administration for the treatment of depression. CONCLUSION Despite advances in modern neuropharmacological treatment, refractory psychiatric illness is common. Electroconvulsive therapy remains the most potent modality currently available for the treatment of depressive illness as well as for mania and some psychotic disorders. It has been used worldwide for more than 6 decades and has a proven record of safety and efficacy, even in patients with advanced concurrent medical or neurologic illness. However, ECT involves the use of general anesthesia, has potent cognitive adverse effects, and is not universally effective. Thus, there is a need for newer techniques with the same excellent clinical benefits as ECT but with fewer adverse effects. Two emerging technologies, TMS and VNS, may become part of the neuropsychiatric therapeutic armamentarium. REFERENCES 1. Abrams R. Electroconvulsive Therapy. 3rd ed. New York, NY: Oxford University Press; Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328: American Psychiatric Association Committee on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd ed. Washington, DC: American Psychiatric Association; Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry. 1993;34: Nobler MS, Sackeim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorders, III: treatment and clinical response. Arch Gen Psychiatry. 1994;51: Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:
5 Krystal AD, Holsinger J, Weiner RD, Coffey CE. Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices. J ECT. 2000;16: George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry. 1999;56: Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;47: Fisher RS, Handforth A. Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1999;53: George MS, Sackeim HA, Marangell LB, et al. Vagus nerve stimulation: a potential therapy for resistant depression? Psychiatr Clin North Am. 2000;23: Questions About Treatment of Medication-Refractory Mental Illness 1. Which one of the following most likely indicates further medical investigation before clearance for ECT? a. Patient complains of sore throat b. Electrocardiogram shows nonspecific T-wave abnormalities c. Patient complains of exertional chest tightness d. Patient has mildly elevated liver function test results e. Patient has long-standing headaches 2. Which one of the following most appropriately indicates referral for ECT? a. Patient with poorly compensated congestive heart failure who is depressed but still functional at work b. Patient with Parkinson disease whose depression is refractory to 2 medication trials and who is becoming increasingly suicidal c. Epileptic patient with pronounced anxiety d. Agitated patient with Alzheimer disease e. Patient with obsessive-compulsive disorder that is highly refractory to medication and who has poorly controlled hypertension 3. Which one of the following is not true regarding the memory disturbances caused by ECT? a. Immediate posttreatment confusion usually clears within a few hours b. Anterograde amnesia is reversible c. Patient forgets something that happened a few weeks before treatments were initiated d. Retrograde amnesia can be permanent e. Modification of electrode placements and electrical doses probably has no bearing on memory disturbance 4. Which one of the following is true about TMS? a. Involves general anesthesia b. Causes about the same memory impairment as ECT c. Was first used clinically to test integrity of motor pathways d. Is commonly used for depression in clinical care e. Is commonly used to elicit seizures 5. Which one of the following is true regarding VNS? a. Is approved for use in refractory partial-onset epilepsy b. Has been shown to be superior to ECT in clinical trials c. Has been shown to have the greatest efficacy for anxiety disorders d. Involves electrical stimulation of vagal efferents as the intended mechanism e. Rarely causes hoarseness Correct answers: 1. c, 2. b, 3. e, 4. c, 5. a
Neuromodulation Approaches to Treatment Resistant Depression
1 Alternative Treatments: Neuromodulation Approaches to Treatment Resistant Depression Audrey R. Tyrka, MD, PhD Assistant Professor Brown University Department of Psychiatry Associate Chief, Mood Disorders
More informationThe New Clinical Science of ECT
The New Clinical Science of ECT C. Edward Coffey, MD Professor of Psychiatry & Behavioral Sciences, and of Neurology Baylor College of Medicine Houston, Texas Fellow and Past President, International Society
More informationVO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT)
VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT) Diagnostic Guidelines: Introduction: Electroconvulsive Therapy has been in continuous use for more than 60 years. The clinical literature
More informationPsychopharmacology 1: ECT
Psychopharmacology 1: ECT Paul Glue paul.glue@otago.ac.nz August 2017 How do antidepressants work? Early theories neurotransmitter deficiency - Unable to demonstrate; doesn t account for diversity of antidepressant
More informationFrequently Asked Questions FAQS. NeuroStar TMS Therapies
Frequently Asked Questions FAQS NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 FAQS About TMS Therapies Page 1 NeuroStar
More informationElectro-Convulsive Therapy Goals. Electro-Convulsive Therapy: Update Ambulatory Surgery Center at UCSF. Outline
: Update 2008 Descartes Li, M.D. Associate Clinical Professor Department of Psychiatry University of California, San Francisco Goals By the end of the seminar, a participant should be able to: Describe
More informationrtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies
rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies rtms Treatment Equipment rtms Equipment Positioning of coil ECT & rtms Innovative Treatment Options for Patients Only a fraction
More informationLIMITATIONS OF MOTOR SEIZURE MONITORING IN ECT
Indian J. Psychiat, 1998, 40 (1), 55-59 LIMITATIO OF MOTOR SEIZURE MONITORING IN ECT M.S. JAYAPRAKASH, B.N. GANGADHAR, N. JANAKIRAMAIAH & D.K. SUBBAKRISHNA ABSTRACT Seizures were monitored using both cuff
More informationLaurence M. Hirshberg, Sufen Chiu, and Jean A. Frazier
EMERGING INTERVENTIONS Foreword Melvin Lewis xi Preface Laurence M. Hirshberg, Sufen Chiu, and Jean A. Frazier xiii Emerging Brain-Based Interventions for Children and Adolescents: Overview and Clinical
More informationPatient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
Dr. Zahida Tayyib www.mvptms.com Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder If you are considering Brainsway Deep treatment
More informationReprinted from the German Journal of Psychiatry ISSN Worrawat Chanpattana
Reprinted from the German Journal of Psychiatry http://www.gjpsy.uni-goettingen.de ISSN 1433-1055 Seizure Threshold in Electroconvulsive Therapy: Effect of Instrument Titration Schedule Worrawat Chanpattana
More informationBiological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy
Biological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy Basic trainee talk 23 May 2007 ECT When is ECT used. Depression. Severe, melancholic. Resistant to treatment.
More informationRepetitive transcranial magnetic stimulation for depression
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Repetitive transcranial magnetic stimulation for depression Depression causes low mood or sadness that can
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abuse alcohol, aggression and, 52 53 substance, aggression and, 52 54 ACE. See Aid to Capacity Evaluation (ACE). AEDs. See Antiepileptic
More informationTranscranial Magnetic Stimulation for the Treatment of Depression
Transcranial Magnetic Stimulation for the Treatment of Depression Paul E. Holtzheimer, MD Associate Professor Departments of Psychiatry and Surgery Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock
More informationThe Next Chapter in Brain Stimulation Therapy
The Next Chapter in Brain Stimulation Therapy Outline I. Depression and Treatment Resistant Depression Barriers to Treatment Treatment Options Cost and Impact of Depression II. Electroconvulsive Therapy
More informationDEEP TMS TREATMENT CONSENT FORM
DEEP TMS TREATMENT CONSENT FORM My doctor has recommended that I receive treatment with Brainsway Deep TMS. The nature of this treatment, including the benefits and risks that I may experience, has been
More informationBrain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN
Brain Stimulation American Psychiatric Nurses Association 24th Annual Conference October 16, 2010 Kentucky International Convention Center Louisville, Kentucky 1 Berry S. Anderson, PhD, RN Mary Rosedale,
More informationStatement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17
Statement on Repetitive Transcranial Magnetic Stimulation for Depression Position statement CERT03/17 Approved by the Royal College of Psychiatrists, Committee on ECT and Related Treatments: February 2017
More informationarxiv: v1 [q-bio.nc] 9 Dec 2011
Long Brief Pulse Method for Pulse-wave modified Electroconvulsive Therapy Hiroaki Inomata, 1,2,3, Hirohiko Harima, 1 and Masanari Itokawa 1,3 1 Tokyo Metropolitan Matsuzawa Hospital 2 Yokohama City University
More informationTMS: Full Board or Expedited?
TMS: Full Board or Expedited? Transcranial Magnetic Stimulation: - Neurostimulation or neuromodulation technique based on the principle of electro-magnetic induction of an electric field in the brain.
More informationElectroconvulsive therapy and its place in the management of depression Ankush Singhal MD, MRCPsych
ECT for depression z Review Electroconvulsive therapy and its place in the management of depression Ankush Singhal MD, MRCPsych Electroconvulsive therapy (ECT) is a psychiatric treatment with a controversial
More informationAP PSYCH Unit 13.3 Biomedical Therapies
AP PSYCH Unit 13.3 Biomedical Therapies Prescribed medications or medical procedures that act directly on the patient s nervous system. Drugs that alter brain chemistry Affecting brain circuitry with electric
More informationTHE PRACTICE OF ECT. Kiran Rabheru
THE PRACTICE OF ECT Kiran Rabheru MD, CCFP, FRCP Geriatric Psychiatrist Professor University of Ottawa February 11, 2015 U of Ottawa Review Course in Psychiatry: Dr. K. Rabheru 1 Disclosures n NONE 2 Learning
More informationPlease read the following important safety requirements before using the Thymatron System IV ECT Instrument.
Caution: Federal law restricts this device to sale by or on the order of a licensed physician. ECT is a complex medical procedure. Its proper and safe conduct requires a staff of licensed healthcare professionals
More informationBRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?
BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION? Kira Stein, MD Medical Director West Coast Life Center Sherman Oaks, California CA Maternal Mental Health Initiative - 2013 2013
More informationHelp and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication
Help and Healing: Resources for Depression Care and Recovery Section 2: Treatment Planning Treatment and Timelines Depression Treatment Reference Care Team Communication Provider Education Tool - Questions
More informationDoes Criticism of Electroconvulsive Therapy undermines its benefits: A Critical Review of its Cognitive Adverse Effects
Commentary Does Criticism of Electroconvulsive Therapy undermines its benefits: A Critical Review of its Cognitive Adverse Effects A Rajendran, 1 VS Grewal, 2 Jyoti Prakash 3 1 Department of Psychiatry,
More informationKA-FAI CHUNG, mb bs, mrcpsych, fhkam Department of Psychiatry, University of Hong Kong, Hong Kong SAR, China
Psychiatry and Clinical Neurosciences (2002), 56, 521 526 Regular Article Relationships between seizure duration and seizure threshold and stimulus dosage at electroconvulsive therapy: Implications for
More informationBILATERAL ECT TREATMENT PROTOCOL FOR THE THYMATRON IV Method 1 preferred method to minimise cognitive side-effects.
BILATERAL ECT TREATMENT PROTOCOL FOR THE THYMATRON IV Method 1 preferred method to minimise cognitive side-effects. 1. Measure seizure threshold (ST) in millicoulombs (mc) Set machine at level 2 = 10%
More informationEpilepsy: diagnosis and treatment. Sergiusz Jóźwiak Klinika Neurologii Dziecięcej WUM
Epilepsy: diagnosis and treatment Sergiusz Jóźwiak Klinika Neurologii Dziecięcej WUM Definition: the clinical manifestation of an excessive excitation of a population of cortical neurons Neurotransmitters:
More informationPOLICY TITLE: Transcranial Magnetic Stimulation (TMS)
Departmental Policy POLICY NO.: 200.02.101P POLICY TITLE: Transcranial Magnetic Stimulation (TMS) Submitted by: Daniel Castellanos, MD Title: Founding Chair, Department of Psychiatry & Behavioral Health
More informationTreatment of Depression: A Brief History
2500 82nd Place Urbandale, Ia Treatment of Depression: A Brief History 1960 s to Present Community Based Services SSRI Antidepressants SNRI Antidepressants 1970 s to present 20% of patients do not respond
More informationPractice parameter for use of electroconvulsive therapy with adolescents.
Complete Summary GUIDELINE TITLE Practice parameter for use of electroconvulsive therapy with adolescents. BIBLIOGRAPHIC SOURCE(S) Ghaziuddin N, Kutcher SP, Knapp P, Bernet W, Arnold V, Beitchman J, Benson
More informationIEHP UM Subcommittee Approved Authorization Guidelines Electroconvulsive Therapy- ECT
Electroconvulsive Therapy- ECT Policy: IEHP considers ECT medically necessary for members with the following disorders: 1. Unipolar and bipolar depression. 2. Bipolar mania. 3. Psychotic disorders including
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationAre you not responding to antidepressants?
PATIENTS & RELATIVES Are you not responding to antidepressants? TMS therapy might be the solution for you. Does not affect cognitive function No anesthesia Covered by most private providers Outpatient
More informationRecommendations. for Care of Adults with Epilepsy. Seeking the best treatment from the right doctor at the right time!
Recommendations for Care of Adults with Epilepsy Seeking the best treatment from the right doctor at the right time! Contents This booklet is to help adults and their caregivers know when it is appropriate
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationElectroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT) UHN Information for patients and families Read this booklet to learn: What ECT is and how it works How to prepare for the treatment What you can expect Some side effects
More informationApproximately 70% of childhood SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY PROCEEDINGS. Ronald P. Lesser, MD KEY POINTS
ASIM May p153-158 5/14/01 9:19 AM Page 153 SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY Ronald P. Lesser, MD KEY POINTS Most children with epilepsy refractory to drugs can improve with surgery Temporal lobe
More informationPatient Education Brief. NeuroStar TMS Therapies
Patient Education Brief NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 About Depression Depression is a serious medical
More informationFDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION
FOR IMMEDIATE RELEASE FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION First and Only Non-systemic and Non-invasive Treatment Cleared for Patients Who Have Not Benefited From Prior Antidepressant
More informationECT Seizure Duration: Database Information
Reprinted from the German Journal of Psychiatry http://www.gjpsy.uni-goettingen.de ISSN 1433-1055 ECT Seizure Duration: Database Information Saxby Pridmore 1, Gaye Batt 2, and Hakuei Fujiyama 3 1 University
More informationADMINISTRATIVE POLICY AND PROCEDURE
Page 1 of 6 SECTION: Medical SUBJECT: Electroconvulsive Therapy (ECT) DATE OF ORIGIN: 10/1/96 REVIEW DATES: 7/1/98, 10/1/99, 7/1/02, 7/1/04, 10/1/05, 5/1/09, 1/3/13, 7/1/15, 8/1/16 EFFECTIVE DATE: 3/24/17
More informationCharles H. Kellner, MD
ECT: Learning From Recent Trials Charles H. Kellner, MD Professor, Department of Psychiatry Icahn School of Medicine at Mount Sinai ISCTM Philadelphia, PA 27 September, 2016 Charles H. Kellner, MD Disclosures
More informationEpilepsy & Functional Neurosurgery
Epilepsy & Functional Neurosurgery An Introduction The LSU-Shreveport Department of Neurosurgery Presenting Authors: Neurosurgery Residents & Faculty Epilepsy Neurosurgery What is a seizure? continuous
More informationKeith G. Rasmussen, MD Mayo Clinic Department of Psychiatry Rochester, Minnesota, USA
Keith G. Rasmussen, MD Mayo Clinic Department of Psychiatry Rochester, Minnesota, USA rasmussen.keith@mayo.edu Why is lithium important? Effective for all stages of bipolar disorder acute treatment as
More informationNeuro-MS/D Transcranial Magnetic Stimulator
Neuro-MS/D Transcranial Magnetic Stimulator 20 Hz stimulation with 100% intensity Peak magnetic field - up to 4 T High-performance cooling: up to 10 000 pulses during one session Neuro-MS.NET software
More informationNeurosoft TMS. Transcranial Magnetic Stimulator DIAGNOSTICS REHABILITATION TREATMENT STIMULATION. of motor disorders after the stroke
Neurosoft TMS Transcranial Magnetic Stimulator DIAGNOSTICS REHABILITATION TREATMENT of corticospinal pathways pathology of motor disorders after the stroke of depression and Parkinson s disease STIMULATION
More informationChapter 15: Late Life and Psychological Disorders
\ Chapter 15: Late Life and Psychological Disorders 1. Ageism refers to a. the physical deterioration that accompanies old age. b. the intellectual deterioration that frequently occurs as a person ages.
More informationCan Brain Scans See Depression?
Can Brain Scans See Depression? By BENEDICT CAREY They seem almost alive: snapshots of the living human brain. Not long ago, scientists predicted that these images, produced by sophisticated brainscanning
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: vagus_nerve_stimulation 6/1998 5/2017 5/2018 5/2017 Description of Procedure or Service Stimulation of the
More informationShaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.
Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland,
More informationBME 701 Examples of Biomedical Instrumentation. Hubert de Bruin Ph D, P Eng
BME 701 Examples of Biomedical Instrumentation Hubert de Bruin Ph D, P Eng 1 Instrumentation in Cardiology The major cellular components of the heart are: working muscle of the atria & ventricles specialized
More informationSome newer, investigational approaches to treating refractory major depression are being used.
CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular
More informationAn Introduction to VNS Therapy
An Introduction to VNS Therapy Fewer seizures Shorter seizures Faster recovery Why wait?* To Learn More visit VNSTherapy.co.uk 1 *Individual results may vary Are you struggling with uncontrolled seizures?
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationEpilepsy Pictures Slideshow: Symptoms, Causes and Treatment.
Epilepsy Pictures Slideshow: Symptoms, Causes and Treatment. Reviewed by Louise Chang, MD on Friday, August 12, 2011 What Is Epilepsy? Epilepsy is a disorder of the brain's electrical system. Abnormal
More informationEpilepsy CASE 1 Localization Differential Diagnosis
2 Epilepsy CASE 1 A 32-year-old man was observed to suddenly become unresponsive followed by four episodes of generalized tonic-clonic convulsions of the upper and lower extremities while at work. Each
More informationNeuro-MS/D DIAGNOSTICS REHABILITATION TREATMENT STIMULATION. Transcranial Magnetic Stimulator. of motor disorders after the stroke
Neuro-MS/D Transcranial Magnetic Stimulator DIAGNOSTICS of corticospinal pathway pathology REHABILITATION of motor disorders after the stroke TREATMENT of depression and Parkinson s disease STIMULATION
More informationElectroconvulsive Therapy: A Review of Its Current Status
Jefferson Journal of Psychiatry Volume 19 Issue 1 Article 1 January 2005 Electroconvulsive Therapy: A Review of Its Current Status Tyler Kenning Thomas Jefferson University Ranjnish Mago Thomas Jefferson
More information1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function
Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function In epilepsy abnormal neurons undergo spontaneous firing Cause of abnormal firing is unclear Firing spreads
More informationDEEP BRAIN STIMULATION
DEEP BRAIN STIMULATION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationSurgery for Medically Refractory Focal Epilepsy
Surgery for Medically Refractory Focal Epilepsy Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence
More informationVagus nerve stimulation for refractory epilepsy
Seizure 2001; 10: 456 460 doi:10.1053/seiz.2001.0628, available online at http://www.idealibrary.com on CASE REPORT Vagus nerve stimulation for refractory epilepsy PAUL BOON, KRISTL VONCK, JACQUES DE REUCK
More informationResearch Perspectives in Clinical Neurophysiology
Research Perspectives in Clinical Neurophysiology A position paper of the EC-IFCN (European Chapter of the International Federation of Clinical Neurophysiology) representing ~ 8000 Clinical Neurophysiologists
More informationElectroconvulsive Therapy (ECT) Patient Guide
Electroconvulsive Therapy (ECT) Patient Guide February 2015 This booklet has the information you need to give an informed consent for Electroconvulsive Therapy (ECT). You learn what ECT is, the purpose
More informationCost-benefit of vagus nerve stimulation for refractory epilepsy Boon P, Vonck K, D'Have M, O'Connor S, Vandekerckhove T, De Reuck J
Cost-benefit of vagus nerve stimulation for refractory epilepsy Boon P, Vonck K, D'Have M, O'Connor S, Vandekerckhove T, De Reuck J Record Status This is a critical abstract of an economic evaluation that
More informationWhen & How to Use ECT in Older Adults. Frans Hugo SJOG Midland Hospital, PERTH
When & How to Use ECT in Older Adults Frans Hugo SJOG Midland Hospital, PERTH Frans.Hugo@sjog.org.au When to Use Most effective and rapid treatment for elderly with severe MDD, bipolar mania, bipolar depression
More informationEEG workshop. Epileptiform abnormalities. Definitions. Dr. Suthida Yenjun
EEG workshop Epileptiform abnormalities Paroxysmal EEG activities ( focal or generalized) are often termed epileptiform activities EEG hallmark of epilepsy Dr. Suthida Yenjun Epileptiform abnormalities
More informationEEG IN FOCAL ENCEPHALOPATHIES: CEREBROVASCULAR DISEASE, NEOPLASMS, AND INFECTIONS
246 Figure 8.7: FIRDA. The patient has a history of nonspecific cognitive decline and multiple small WM changes on imaging. oligodendrocytic tumors of the cerebral hemispheres (11,12). Electroencephalogram
More informationZinging the Blues. By Kathy Svitil
Zinging the Blues By Kathy Svitil By using magnetic or electrical stimulation to alter neural activity in the brain, neuromodulation joins medications and psychotherapy as a third domain for the treatment
More informationPsychotropic Drugs 0, 4-
0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID
More informationPage 1 of 18 Volume 01 Page 1
Response to Vagus Nerve Stimulation (VNS) Therapy Treatment-Resistant Depression (TRD) Indication Not Approvable Letter from the United States Food and Drug Administration (FDA), Dated August 11, 2004
More informationSubthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about
More informationElectro-convulsive Therapy (ECT) Your questions answered
Electro-convulsive Therapy (ECT) Your questions answered Q A Welcome This leaflet aims to answer some of the questions you may have about Electro-convulsive Therapy (ECT). You may wish to know why ECT
More informationThe Surgical Treatment of Epilepsy
The Surgical Treatment of Epilepsy Jeffrey S. Schweitzer, MD, PhD Kaiser Los Angeles Medical Center Division of Restorative Neurosurgery Ancient craniotomy When Cao started complaining about splitting
More informationECT in Schizophrenia. Dr Richard Braithwaite Consultant Psychiatrist Isle of Wight NHS Trust
ECT in Schizophrenia Dr Richard Braithwaite Consultant Psychiatrist Isle of Wight NHS Trust ECT in Schizophrenia (not catatonia) Dr Richard Braithwaite Consultant Psychiatrist Isle of Wight NHS Trust Objectives
More informationTranscranial Magnetic Stimulation
Transcranial Magnetic Stimulation Date of Origin: 7/24/2018 Last Review Date: 7/24/2018 Effective Date: 08/01/18 Dates Reviewed: 7/24/2018 Developed By: Medical Necessity Criteria Committee I. Description
More informationMagnetoencephalography
Scan for mobile link. Magnetoencephalography Magnetoencephalography (MEG) is a non-invasive medical test that measures the magnetic fields produced by your brain s electrical currents. It is performed
More informationSetting up a TMS Treatment Program
Setting up a TMS Treatment Program Alvaro Pascual-Leone, M.D., Ph.D. Professor in Neurology Harvard Medical School Beth Israel Deaconess Medical Center Daniel Cohen, M.D., M.M.Sc. Instructor in Neurology
More informationIOM at University of. Training for physicians. art of IOM. neurologic. injury during surgery. surgery on by IOM. that rate is.
Topics covered: Overview of science and art of IOM IOM at University of Michigan Hospital and Health Systems What is the purpose of Intraoperative monitoring? Training for physicians Overview of science
More informationTo Learn More. An Introduction to VNS Therapy. call or visit VNSTherapy.com
An Introduction to VNS Therapy Fewer seizures. Shorter seizures. Faster recovery. Why wait?* To Learn More call 1-888-867-7846 or visit VNSTherapy.com *Individual results may vary Are you struggling with
More informationSurgical Treatment for Movement Disorders
Surgical Treatment for Movement Disorders Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence St Vincent
More informationRepetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders
Repetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders Policy Number: Original Effective Date: MM.12.015 08/01/2014 Line(s)
More informationMental Health Rotation Educational Goals & Objectives
Mental Health Rotation Educational Goals & Objectives Mental illness is prevalent in the general population and is commonly seen and treated in the office of the primary care provider. Educational experiences
More informationELECTROCONVULSIVE THERAPY EFFECTS ON COGNITION AND MEMORY AND NURSE S ROLE
PERIOPERATIVE NURSING (2016), VOLUME 5, ISSUE 2 REVIEW ARTICLE ELECTROCONVULSIVE THERAPY EFFECTS ON COGNITION AND MEMORY AND NURSE S ROLE Antonia Stergiopoulou RN, Msc, Phd National and Kapodistrian University
More informationInformation about ELECTROCONVULSIVE THERAPY (ECT)
Information om behandling med ECT For adults Information about ELECTROCONVULSIVE THERAPY (ECT) Psykiatri og Social psykinfomidt.dk CONTENTS 03 What is ECT? 03 Who can have ECT treatment? 05 How does ECT
More informationWhat is NBS? Nextstim NBS System
Nextstim NBS System What is NBS? NBS means navigated brain stimulation, and is used to precisely map the areas controlling muscle movements/activity in the brain. This procedure provides advanced patient
More informationNoninvasive Neuromodulation Current State & Future Directions
Sarah H. Lisanby, MD Director, Translational Research Division Team B Lead BRAIN Initiative Chief, Noninvasive Neuromodulation Unit Noninvasive Neuromodulation Current State & Future Directions Experimental
More informationThere are several types of epilepsy. Each of them have different causes, symptoms and treatment.
1 EPILEPSY Epilepsy is a group of neurological diseases where the nerve cell activity in the brain is disrupted, causing seizures of unusual sensations, behavior and sometimes loss of consciousness. Epileptic
More informationBiomedical Research 2013; 24 (3): ISSN X
Biomedical Research 2013; 24 (3): 359-364 ISSN 0970-938X http://www.biomedres.info Investigating relative strengths and positions of electrical activity in the left and right hemispheres of the human brain
More informationAre they still doing that?
Are they still doing that? Why we still give ECT and when to refer Nicol Ferrier BSc (Hons), MD, FRCP(Ed), FRCPsych Emeritus Professor of Psychiatry Newcastle University Rates of prescribing ECT in the
More informationThe Electroencephalogram: Pre- and Post-Evaluations in Variable. Somatic Therapies
The Electroencephalogram: Pre- and Post-Evaluations in Variable Somatic Therapies Alfred E. Eyres, M.D.¹ Juanita Gendernelle, R.N.,² and Margaret DeGuvara, R.N. ³ Computer analysis of the Index Medi-cus
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Transcranial Magnetic Stimulation (TMS) Page 1 of 21 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Transcranial Magnetic Stimulation (TMS) Vagus Nerve
More informationEffects of Sleep and Circadian Rhythms on Epilepsy
Effects of Sleep and Circadian Rhythms on Epilepsy Milena Pavlova, M.D. Medical Director, Faulkner Neurophysiology Laboratory Department of Neurology, Brigham and Women s Hospital Harvard Medical School
More informationª The Author(s) The Canadian Journal of Psychiatry / La Revue Canadienne de Psychiatrie 1-15
Canadian Psychiatric Association Association des psychiatres du Canada Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive
More informationPhysiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR
Physiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR In Physiology Today What the Brain Does The nervous system determines states of consciousness and produces complex behaviors Any given neuron may
More information